Refractive Surgery

>

Latest News

FDA Approves TENEO Excimer Laser Platform from Bausch + Lomb
FDA Approves TENEO Excimer Laser Platform from Bausch + Lomb

January 8th 2024

The device is intended for use for LASIK vision correction surgery for myopia and myopic astigmatism.

FDA gives its blessing to Ocuphire Pharma’s special protocol assessment for LYNX-2 Phase 3 clinical trial
FDA gives its blessing to Ocuphire Pharma’s special protocol assessment for LYNX-2 Phase 3 clinical trial

January 4th 2024

Two-year results of laser scleral microporation
Two-year results of laser scleral microporation

November 16th 2023

(Adobe Stock / © Axel Kock)
AAO 2023: Spotlight on IOLs

November 1st 2023

Creating a positive patient financial journey for refractive error procedures
Creating a positive patient financial journey for refractive error procedures

September 18th 2023

More News

© 2024 MJH Life Sciences

All rights reserved.